Citations

Clear

861 citation(s) found for "Sd, Wexner".

S1428 Using Age as a Predictor of Outcomes After Transjugular Intrahepatic Portosystemic Shunt
Waidyaratne, Gavisha , Liyanarachchi, Sandya , Ma, Jianing , Acharya, Chathur , Mendiratta, Vivek, Kelly, Sean G. , Conteh, Lanla , Sobotka, Lindsay A. , Wellner, Michael, Mumtaz, Khalid , Jalil, Sajid , Liu, Alex C.H. , Peng, Jing

Mayo Clinic

American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S1089-S1090

10.14309/01.ajg.0000955352.88032.e0 Get It

Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors
Shatara, Margaret , Blue, Megan, Stanek, Joseph , Prevedello, Daniel M. , Giglio, Pierre , Puduvalli, Vinay K. , Wong, Kenneth , Nelson, Marvin D. , Gilles, Floyd H. , Adams, Roberta H. , Pauly, Jasmine, O’Halloran, Katrina , Dhall, Girish , Giglio, Pierre , Puduvalli, Vinay K , Dhall, Girish , Prevedello, Daniel M , Liu, Yin , Gardner, Sharon L , Allen, Jeffrey C. , Margol, Ashley , Finlay, Jonathan L.

Mayo Clinic

Neuro-Oncology Practice | October 13, 2023 | Volume: 11 | Issue: 2 | Pages: 188-198

10.1093/nop/npad067 | PMID 38496907 Get It

Abstract Background Patients with relapsed intracranial germinoma can achieve durable remission with standard chemotherapy regimens and/or reirradiation; however, innovative therapies are required for patients with relapsed and/or refractory intracranial nongerminomatous germ cell tumors (NGGCTs) due to their poor prognosis. Improved outcomes have been reported using reinduction chemotherapy to achieve minimal residual disease, followed by marrow-ablative chemotherapy (HDCx) with autologous hematopoietic progenitor cell rescue (AuHPCR). We conducted a phase II trial evaluating the response and toxicity of a 3-drug combination developed for recurrent intracranial germ cell tumors consisting of gemcitabine, paclitaxel, and oxaliplatin (GemPOx). Methods A total of 9 patients with confirmed relapsed or refractory intracranial GCT were enrolled after signing informed consent, and received at least 2 cycles of GemPOx, of which all but 1 had relapsed or refractory NGGCTs. One patient with progressive disease was found to have pathologically confirmed malignant transformation to pure embryonal rhabdomyosarcoma (without GCT elements), hence was ineligible and not included in the analysis. Patients who experienced sufficient responses proceeded to receive HDCx with AuHPCR. Treatment response was determined based on radiographic tumor assessments and tumor markers. Results A total of 7 patients achieved sufficient response and proceeded with HDCx and AuHPCR, and 5 subsequently received additional radiotherapy. A total of 2 patients developed progressive disease while receiving GemPOx. Myelosuppression and transaminitis were the most common treatment-related adverse events. With a mean follow-up of 44 months, 4 patients (3 NGGCTs, 1 germinoma) are alive without evidence of disease. Conclusions GemPOx demonstrates efficacy in facilitating stem cell mobilization, thus facilitating the feasibility of both HDCx and radiotherapy.
Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy
Hálfdánarson, Þorvarður R. , Mallak, Nadine , Paulson, Scott, Natwa, Mona, Kendi, A. Tuba , Kennecke, Hagen F. , Kendi, A Tuba , Halfdanarson, Thorvardur R , Chandrasekharan, Chandrikha

Mayo Clinic

Cancers | October 2, 2023 | Volume: 15 | Issue: 19 | Pages: 4836

10.3390/cancers15194836 | PMID 37835530 Get It

Radioligand therapy (RLT) with [177Lu]Lu-DOTA-TATE is a standard of care for adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Taking advantage of this precision nuclear medicine approach requires diligent monitoring and surveillance, from the use of diagnostic SSTR-targeted radioligand imaging for the selection of patients through treatment and assessments of response. Published evidence-based guidelines assist the multidisciplinary healthcare team by providing acceptable approaches to care; however, the sheer heterogeneity of GEP-NETs can make these frameworks difficult to apply in individual clinical circumstances. There are also contradictions in the literature regarding the utility of novel approaches in monitoring and surveilling patients with GEP-NETs receiving RLT. This article discusses the emerging evidence on imaging, clinical biochemistry, and tumor assessment criteria in the management of patients receiving RLT for GEP-NETs; additionally, it documents our own best practices. This allows us to offer practical guidance on how to effectively implement monitoring and surveillance measures to aid patient-tailored clinical decision-making.
Quality measures for the care of pediatric patients with obstructive sleep apnea: 2023 update after measure maintenance
Lloyd, Robin M. , Crawford, T’Auna, Donald, Ryan, Gray, Diedra D., Junna, Mithri R. , Lewin, Daniel , Revana, Amee , Schutte-Rodin, Sharon, Healy, William J.

Mayo Clinic

Journal of Clinical Sleep Medicine | September 29, 2023 | Volume: 20 | Issue: 1 | Pages: 127-134

10.5664/jcsm.10836 | PMID 37772707 Get It

Artificial Intelligence-guided Resistance Training Maintained Improved Patient-reported Outcomes In Subjects With Low Back Pain
Breuer, Logan, Alzouhayli, Kenan , Holmes, Benjamin D. , McPherson, April L. , Schilaty, Nathan D. , Nagai, Takashi , Rigamonti, Luca, Bates, Nathaniel A.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 503-503

10.1249/01.mss.0000984488.61893.b4 Get It

Effects Of Artificial Intelligence-guided Resistance Training On 52-week Clinical Visits In Low Back Pain Subjects
Alzouhayli, Kenan , Breuer, Logan, Holmes, Benjamin D. , Bates, Nathaniel A. , Nagai, Takashi , Rigamonti, Luca, Holmes, Benjamin, Schilaty, Nathan D.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 503-503

10.1249/01.mss.0000984484.53699.1e Get It

Incidence Of Illnesses Among Team Usa Athletes Competing In The Beijing 2022 Winter Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Finnoff, Jonathan T. , Clark, Stephanie C., McPherson, April L. , Robinson, David M. , Adams, William M.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 81-82

10.1249/01.mss.0000980448.16663.ff Get It

Incidence Of Injuries Among Team Usa Athletes Competing In The Beijing 2022 Winter Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 80-80

10.1249/01.mss.0000980432.27799.f1 Get It

Incidence Of Injuries Among Team Usa Athletes Competing In The Beijing 2022 Winter Olympic Games
Noble-Taylor, Kayle E., Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 74-74

10.1249/01.mss.0000980392.16649.bc Get It

Incidence Of Illness Among Team Usa Athletes Competing In The 2022 Beijing Winter Olympic Games
Clark, Stephanie C., Cali, Malia G. , Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 79-79

10.1249/01.mss.0000980424.22415.75 Get It